Crescent Biopharma, Inc. (CBIO): Weighted Average Diluted Shares
64.48M
Year ended 2024-12-31
+7.8%
3-year compound annual growth
+8.3%
5-year compound annual growth
+13.3%
10-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | 64.48M | +1.8% | 2025-02-13, From 2024-01-01 |
| 2023-12-31 | 63.34M | +20.6% | 2025-02-13, From 2023-01-01 |
| 2022-12-31 | 52.53M | +2.1% | 2024-03-27, From 2022-01-01 |
| 2021-12-31 | 51.45M | +12.5% | 2024-03-27, From 2021-01-01 |
| 2020-12-31 | 45.72M | +5.7% | 2023-03-29, From 2020-01-01 |
| 2019-12-31 | 43.25M | n/a | 2022-03-03, From 2019-01-01 |
| No annual figure between 2014-12-31 and 2019-12-31. | |||
| 2014-12-31 | 18.45M | n/m | 2015-03-16, From 2014-01-01 |
| 2013-12-31 | 1.20M | -89.1% | 2015-03-16, From 2013-01-01 |
| 2012-12-31 | 11.02M | n/a | 2015-03-16, From 2012-01-01 |